Blood News and Research

RSS

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

New guidelines for heart-healthy eating

We speak to Dr. Alice Lichtenstein about the American Heart Association’s latest guidelines for a heart-healthy diet, and how they can be applied across different lifestyles.

14 Dec 2021

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

An interesting new paper presents a new assay for B and T lymphocytes in individuals infected with SARS-CoV-2.

14 Dec 2021

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

14 Dec 2021

Study may offer insights into novel therapeutic strategies to treat COVID-19 related blood clots

Blood clots or thromboembolic complications in patients with COVID-19 are associated with increased levels of various proteins that cause blood to clot, compared with people with blood clots unrelated to COVID-19, according to a small study by Yale Cancer Center researchers.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Lymphoma patients can benefit from early CAR T treatment, study shows

Chimeric antigen receptor T-cell therapy or CAR T is a breakthrough treatment for patients with certain types of blood cancers.

13 Dec 2021

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

For patients with the blood cancer multiple myeloma, vaccination against COVID-19 provides some protection against coronavirus infection but to a far lower degree than the general population of cancer survivors, a new study by Dana-Farber Cancer Institute investigators shows.

13 Dec 2021

Large study reveals increased rates of myeloma precursor condition in high-risk groups

The first results from the largest screening study yet conducted in the United States of individuals at above-average risk for the blood cancer multiple myeloma have revealed higher rates of a myeloma precursor condition in older adults who are Black or who have a close family member with a current or past blood cancer.

13 Dec 2021

Air pollution can cause serious health consequences to more than 600 million people in South Asia

With another smoggy winter hanging over the vast and thickly populated Indo-Gangetic plains, there are fears of serious health consequences to more than 600 million people living in northern India and Nepal as well as in eastern Pakistan and Bangladesh.

13 Dec 2021

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

Persons experiencing homelessness (PEH) who were at high risk of severe COVID-19 were 2.5 times less likely to contract SARS-CoV-2 if they were provided with individual hotel rooms and medical and social support compared to citywide rates in homeless shelters, according to new research from the University of Chicago Medicine, Lawndale Christian Health Center, and the Chicago Department of Public Health.

13 Dec 2021

Henry Ford surgeons use unique approach to perform first precision prostatectomy

Surgeons at Henry Ford Health System's Vattikuti Urology Institute performed what is believed to be the first precision prostatectomy through the bladder using a single port robotic surgical system.

13 Dec 2021

Study offers new hope for large B-cell lymphoma patients

Of the 18,000 people diagnosed with large B-cell lymphoma each year, only half will be successfully treated with chemotherapy. The 9,000 remaining patients typically have poor outcomes, with only 25% responding to additional, higher-intensity chemotherapy, followed by a stem cell transplant.

13 Dec 2021

Blood News and Research

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New guidelines for heart-healthy eating

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

Study may offer insights into novel therapeutic strategies to treat COVID-19 related blood clots

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Lymphoma patients can benefit from early CAR T treatment, study shows

COVID-19 vaccines offer protection for multiple myeloma patients, but lesser than other cancer survivors

Large study reveals increased rates of myeloma precursor condition in high-risk groups

Air pollution can cause serious health consequences to more than 600 million people in South Asia

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

Henry Ford surgeons use unique approach to perform first precision prostatectomy

Study offers new hope for large B-cell lymphoma patients

New England research on population immunity and SARS-CoV-2

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Diversity in genetic data improves the ability to predict high cholesterol risk

People with HIV more likely to develop heart failure, study finds

Using cannabis alongside other drugs may lead to harmful drug-drug interactions

WHO and St. Jude announce plans to improve children's access to cancer medicines

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News